
Valinor Discovery provides AI-powered simulations of therapeutic efficacy to speed up drug development. It uses state-of-the-art machine learning models trained on patient-derived datasets to predict target gene responses, patient stratification, adverse effects, disease associations, and clinical endpoints. As a SaaS platform, it enables data-driven decisions before wet-lab experiments and clinical trials. Core tech includes multi-omic data integration and predictive modeling to support hit-to-lead, competitive analysis, and drug repurposing. The system targets drug development companies seeking faster, cost-efficient exploration from discovery to clinic.

Valinor Discovery provides AI-powered simulations of therapeutic efficacy to speed up drug development. It uses state-of-the-art machine learning models trained on patient-derived datasets to predict target gene responses, patient stratification, adverse effects, disease associations, and clinical endpoints. As a SaaS platform, it enables data-driven decisions before wet-lab experiments and clinical trials. Core tech includes multi-omic data integration and predictive modeling to support hit-to-lead, competitive analysis, and drug repurposing. The system targets drug development companies seeking faster, cost-efficient exploration from discovery to clinic.